WO2001021207A2 - Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines - Google Patents

Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines Download PDF

Info

Publication number
WO2001021207A2
WO2001021207A2 PCT/EP2000/009366 EP0009366W WO0121207A2 WO 2001021207 A2 WO2001021207 A2 WO 2001021207A2 EP 0009366 W EP0009366 W EP 0009366W WO 0121207 A2 WO0121207 A2 WO 0121207A2
Authority
WO
WIPO (PCT)
Prior art keywords
vaccine
antigen
virus
polyoxyethylene sorbitan
use
Prior art date
Application number
PCT/EP2000/009366
Other languages
French (fr)
Other versions
WO2001021207A3 (en
Inventor
Martin Friede
Philippe Hermand
Veronique Henerickx
Original Assignee
Smithkline Beecham Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB9922703.5 priority Critical
Priority to GBGB9922703.5A priority patent/GB9922703D0/en
Priority to GB0016685A priority patent/GB0016685D0/en
Priority to GB0016685.0 priority
Application filed by Smithkline Beecham Biologicals S.A. filed Critical Smithkline Beecham Biologicals S.A.
Publication of WO2001021207A2 publication Critical patent/WO2001021207A2/en
Publication of WO2001021207A3 publication Critical patent/WO2001021207A3/en

Links